(HealthDay)—For medical students, self-reported confidence in prescribing only weakly correlates with actual competence, according to a study published online Feb. 4 in The Journal of Clinical Pharmacology.
Feb 10, 2015
0
6
Patients suffering from early symptoms of Alzheimer's disease who were diagnosed sooner than usual using a brain imaging test received Alzheimer-specific medications earlier than those who did not have the brain imaging results ...
Sep 24, 2013
0
0
A new study of genetically modified immune cells by scientists from UCLA and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.
Mar 22, 2013
0
0
The bacteria that cause acne live on everyone's skin, yet one in five people is lucky enough to develop only an occasional pimple over a lifetime. What's their secret?
Feb 28, 2013
0
0
Liposarcoma, the most common type of sarcoma, is an often lethal form of cancer that develops in fat cells. It is particularly deadly, in part, because the tumors are not consistently visible with positron emission tomography ...
Dec 10, 2012
0
0
(HealthDay)—Although use of recombinant human erythropoietin (rHuEPO) is prohibited among athletes because it reportedly enhances performance, there is no scientific evidence that it does so, according to a study published ...
Dec 10, 2012
0
0
Each year, about 610,000 Americans suffer their first heart attack, according to the Centers for Disease Control and Prevention. Heart attacks and other symptoms of cardiovascular disease can be caused when blockage occurs ...
Dec 6, 2012
0
1
The drug erythropoietin, often called EPO, is banned from sports because it is believed to enhance an athlete's performance and give people who use it an unfair advantage over unenhanced competitors. However a new systemic ...
Dec 5, 2012
0
0
(Medical Xpress)—Children who are given anaesthetic before the age of three may have an increased risk of developing learning difficulties, according to a new study involving researchers at The University of Western Australia.
Aug 28, 2012
0
0
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.
Apr 1, 2012
0
0
